HemaCare (OTCMKTS:HEMA) Stock Price Up 0.6% – What’s Next?

HemaCare Co. (OTCMKTS:HEMA – Get Free Report) shares traded up 0.6% on Monday . The stock traded as high as $25.31 and last traded at $25.31. 5,400 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.

HemaCare Price Performance

The stock’s 50 day simple moving average is $25.31 and its two-hundred day simple moving average is $25.31.

HemaCare Company Profile

(Get Free Report)

HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.

See Also

• Five stocks we like better than HemaCare
• How to Plot Fibonacci Price Inflection Levels
• What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health
• Election Stocks: How Elections Affect the Stock Market
• 3 Stocks Most Likely to Split in 2026
• The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
• ChargePoint’s Comeback Story: Why This EV Stock Is Charging Up Again